Cash & equivalents increased 29.1%
Cash & equivalents changed +29.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +29.1% from the comparable as-filed period.
Net income changed +5391.6% from the comparable as-filed period.
Operating income changed +51.1% from the comparable as-filed period.
Operating margin changed +305 basis points from the comparable as-filed period.
Revenue changed +14.9% from the comparable as-filed period.
Research & development changed +6.2% from the comparable as-filed period.
Stock-based compensation changed -8.7% from the comparable as-filed period.
Selling, general & administrative changed +0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.